The first relevant result in our study was that DPPIV showed higher activity and mRNA levels in preneoplastic adenomatous lesions and in CRC when compared with the uninvolved surrounding mucosa, although it did not correlate with pathological variables and with 5-year survival of CRC patients. This evidence concerns the gene FAP and colorectal carcinoma.